EUCTR2013-001222-26-DK进行中（未招募）1 期
Markers of bonestatus in Diabetes Mellitus patients (type 1 and type 2) andthe effect of antiresorptive treatment on glycemic markers.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Type 1 diabetes / type 2 diabetes
- •Age = 50 år.
- •Same medical diabetes treatment the last six months (dose changes
- •is allowed)and HbA1c changes on ± 1 in the same period.
- •HbA1c level= 6,7% in the last six months.
- •Body mass index (BMI) between 19 og 35.
- •DXA T-score: -3,5 til -0,5.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 32
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 32
排除标准
- •HbA1C > 10%
- •Pregnancy.
- •Metal implanted at ancle and wrist at all four ekstremities.
- •Treatment by: Antiresorptives (inkl. HRT) or bone anabolic drugs,
- •glucocorticoids, lithium og anticonvulsives.
- •Patients with bone disease different from Osteoporosis.
- •Vertebral fraktur synlig ved VFA.
- •Patients with kidney disease defined by eGFR < 50.
- •Other significant medical disease in unstable phase (like cancer or
- •hyperthyroidism)
- •Heart failure in NYHA class IV.
- •Previous allergic reactions to the trial drug.
- •Previous allergic reactions to tetracyklin.
- •Abnormities in esophagus and other factors, which may delay the transit tim in the esophagus.
- •Unable to stand or sit for 30 consecutive minutes.
- •The investigator considers the patient unfit to participate.
- •Patient with no understanding of the extent of the trial.
研究者
相似试验
进行中（未招募）
1 期
Markers of bonestatus in Diabetes Mellitus patients (type 1 and type 2) and the effect of antiresorptive treatment on glycemic markersCTIS2024-514148-99-00Aalborg University Hospital64
已完成
不适用
Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)OsteopeniaDiabetes MellitusOsteoporosisNCT01870557Jakob Starup Linde197
已完成
不适用
Characterization of Local and Systemic Bone Markers in Diabetes Patients With Charcot OsteoarthropathyArthropathy, NeurogenicDiabetes ComplicationsDiabetes MellitusNCT02386579Bispebjerg Hospital5
已完成
不适用
Bone Properties Following Exercise Induced Changes in Insulin Sensitivity in People With Type 2 DiabetesBone Diseases, MetabolicOsteoporosis, OsteopeniaMusculoskeletal DiseasesMetabolic DiseaseGlucose Metabolism DisordersInsulin ResistanceDiabetes Mellitus, Type 2NCT06668090Aarhus University Hospital42
尚未招募
不适用
Awareness of Osteoporosis in Diabetes Mellitus PatientsOsteoporosis RiskDiabetes MellitusOsteoporosisDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1NCT05760118Uskudar State Hospital400